Medicare Part D Basics and Policy Options for Redesign

Proposed Legislation and Its Impact

“Key Provisions of Drug Pricing Proposals.” Larosa, J., Slifer, E. Wynne Health Group. April 26, 2021. Available at

“H.R. 3 – Elija E. Cummings Lower Drug Costs Not Act.” Office of Congressman Frank Pallone. April 22, 2021. Available at

“S.909 – Prescription Drug Price Relief Act of 2021.” Office of Senator Bernard Sanders. March 23, 2021. Available at

“What’s the Latest on Prescription Drug Proposals from the Trump Administration, Congress, and the Biden Campaign.” Cubanski, J., Freed, M., Dolan, R. et all. KFF. October 6, 2020. Available at

“Impact of H.R. 3 as Passed by the House on Federal Spending and Drug Manufacturer Revenues.” Cole, M., Brantley, K., Stengel, K. Avalere. June 19, 2020. Available at

“Understanding The Senate Finance Committee’s Drug Pricing Package.” Sachs, R. Health Affairs. July 26, 2019. Available at

“Comparing the Recent Drug-Pricing Reform Proposals.” Hayes, T. American Action Forum. December 10, 2019. Available at

“H.R. 19 – Lower Costs, More Cures Act of 2019.” Office of Congressman Greg Walden. December 19, 2019. Available at

“S.2543 – Prescription Drug Pricing Reduction Act of 2019.” Office of Senator Chuck Grassley. September 25, 2019. Available at

Key Resources

(listed chronologically, beginning with the most recent)

“Frequently Asked Questions About Prescription Drug Pricing and Policy.” Kirchhoff, S., Bodie, A., Sekar, K. et al. Congressional Research Service. May 6, 2021. Available at

“Essential Facts About Drug Pricing Reform: Medicare Part D Redesign.” Martin, K. The Commonwealth Fund. May 5, 2021. Available at

“Democrats Eye Medicare Negotiations to Lower Drug Prices.” Huetteman, E. Kaiser Health News. March 23, 2021. Available at

“How a Medicare Part D Inflation Penalty Would Lower Drug Spending for Patients, Taxpayers, and Employers.’ Anderson-Cook, A., Love, K., Noda, A., et al. Health Affairs. February 5, 2020. Available at

“What to Know about Part D When Working Past 65.” AARP and United HealthCare Services. 2020. Available at

“Assessing Drug Price Increases in Medicare Part D and the Implications of Inflation Limits.” Cubanski, J., Neuman, T. KFF. October 18, 2019. Available at

“What Is an Inflationary Rebate, and How Can It Help Bring Down Drug Prices?” Noda, A., Miller, M. Arnold Ventures. July 22, 2019. Available at

“A Primer on Medicare: Key Facts About the Medicare Program and the People it Covers.” Cubanski, J., Swoope, C., Boccuti, C., et al. KFF. March 20, 2015. Available at

“How Medicare Works.” Blue Cross Blue Shield Blue Care Network. Available at

Additional Resources

(listed chronologically, beginning with the most recent)

“Impacts of Part D Redesign Vary by Therapeutic Area.” Cole, M., Yip, R., Kazan, M. et al. Avalere. February 8, 2021. Available at

“A Dozen Facts About Medicare Advantage in 2020.” Freed, M., Damico, A., Neuman, T. KFF. January 13, 2021. Available at

“International Prescription Drug Price Comparisons: Current Empirical Estimates and Comparisons with Previous Studies.” Mulcahy, A., Whaley, C., Gizaw, M. Rand Corporation. 2021. Available at

“Transparency in Coverage Final Rule Fact Sheet.” Centers for Medicare & Medicaid Services. October 29, 2020. Available at

“Association Between the Percentage of U.S. Drug Sales Subject to Inflation Penalties and the Extent of Drug Price Increases.” Dickson, S. JAMA Network Open. September 1, 2020. Available at

“Total Number of Medicare Beneficiaries.” KFF. 2020 Available at

“Redesigning Medicare Part D to Realign Incentives.” Hayes, T. American Action Forum. August 14, 2018. Available at

Return to event page »